Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2111440 | 0.85 | FDPS (0.37) | FDPSALDH1A1TSHR | |
| Bromide SCHEMBL30442463 | 0.81 | FDPS (0.35) | FDPSALDH1A1TSHR | |
| SCHEMBL105130 | 0.76 | TSHR (0.40) | L3MBTL1ALDH1A1TSHR | |
| SCHEMBL23896733 | 0.76 | ALDH1A1 (0.44) | FDPSALDH1A1TSHR | |
| SCHEMBL23143150 | 0.73 | FDPS (0.30) | FDPS | |
| SCHEMBL7808394 | 0.73 | CES2 (0.34) | FDPS | |
| SCHEMBL23896738 | 0.73 | ALDH1A1 (0.36) | FDPSALDH1A1 | |
| Methyl Alcohol SCHEMBL27684406 | 0.72 | ALDH1A1 (0.38) | L3MBTL1ALDH1A1TSHR | |
| SCHEMBL189800 | 0.69 | — | — | |
| SCHEMBL31421734 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0931082-A4 | NODULISPORIC ACID DERIVATIVES | MERCK & CO INC (US) | 1999-11-17 | — | — | EP | claimed |
| EP-0931082-A1 | NODULISPORIC ACID DERIVATIVES | Merck & Co., Inc. (a New Jersey corp.) (US) | 1999-07-28 | — | — | EP | claimed |
| WO-1998012196-A1 | NODULISPORIC ACID DERIVATIVES | MERCK & CO., INC. (US) | 1998-03-26 | — | — | WO | claimed |
| US-20230038124-A1 | NOVEL SUBSTITUTED CONDENSED RING COMPOUND | Sumitomo Pharma Co., Ltd. (JP) | 2023-02-09 | — | — | US | disclosed |
| US-20230023559-A1 | ARYLMETHYLENE HETEROCYCLIC COMPOUNDS AS KV1.3 POTASSIUM SHAKER CHANNEL BLOCKERS | D. E. SHAW RESEARCH, LLC (US) | 2023-01-26 | — | — | US | disclosed |
| US-9458171-B2 | Pyrrolidinyl sulfone RORγ modulators | BRISTOL-MYERS SQUIBB COMPANY (US) | 2016-10-04 | — | — | US | disclosed |
| US-20150191483-A1 | PYRROLIDINYL SULFONE RORGAMMA MODULATORS | BRISTOL-MYERS SQUIBB COMPANY | 2015-07-09 | — | — | US | disclosed |
| US-8232288-B2 | Substituted benzimidazoles, benzothiazoles and benzoxazoles | GRUENENTHAL GMBH (DE) | 2012-07-31 | — | — | US | disclosed |
| US-20110009382-A1 | Substituted Benzimidazoles, Benzothiazoles and Benzoxazoles | GRUENENTHAL GMBH (DE) | 2011-01-13 | — | — | US | disclosed |
| US-7622468-B2 | Mitotic kinesin inhibitors | MERCK & CO. INC. (US) | 2009-11-24 | — | — | US | disclosed |
| US-20090042854-A1 | Hexahydro-3H-Pyrrolizin-3-Ones Useful as Tachykinin Receptor Antagonists | MERCK SHARP & DOHME CORP. | 2009-02-12 | — | — | US | disclosed |
| EP-0931082-B1 | NODULISPORIC ACID DERIVATIVES | MERCK & CO INC (US) | 2003-03-19 | — | — | EP | disclosed |
| US-6221894-B1 | ACARICIDAL, ANTIPARASITIC, INSECTICIDAL AND ANTHELMINTIC AGENTS. | MERCK & CO., INC. | 2001-04-24 | — | — | US | disclosed |
| EP-0931082-A4 | NODULISPORIC ACID DERIVATIVES | MERCK & CO INC (US) | 1999-11-17 | — | — | EP | disclosed |
| US-5962499-A | ACARICIDAL, ANTIPARASITIC, INSECTICIDAL AND ANTHELMINTIC AGENTS | MERCK & CO., INC. (US) | 1999-10-05 | — | — | US | disclosed |
| EP-0931082-A1 | NODULISPORIC ACID DERIVATIVES | Merck & Co., Inc. (a New Jersey corp.) (US) | 1999-07-28 | — | — | EP | disclosed |
| WO-1998012196-A1 | NODULISPORIC ACID DERIVATIVES | MERCK & CO., INC. (US) | 1998-03-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090042854-A1 | Hexahydro-3H-Pyrrolizin-3-Ones Useful as Tachykinin Receptor Antagonists | TACR1, PROKR1, TACR2 | FDPS 2442/4885L3MBTL1 4768/4885ALDH1A1 1161/4885 |
| US-20230038124-A1 | NOVEL SUBSTITUTED CONDENSED RING COMPOUND | CYP51A1, HDAC11, MMP9 | FDPS 1084/4885L3MBTL1 1686/4885ALDH1A1 232/4885 |
| US-20110009382-A1 | Substituted Benzimidazoles, Benzothiazoles and Benzoxazoles | BDKRB1, BDKRB2, BRD1 | FDPS 3619/4885L3MBTL1 3311/4885ALDH1A1 1533/4885 |
| US-20230023559-A1 | ARYLMETHYLENE HETEROCYCLIC COMPOUNDS AS KV1.3 POTASSIUM SHAKER CHANNEL BLOCKERS | KCNJ2, KCNA3, KCNH3 | FDPS 2990/4885L3MBTL1 3831/4885ALDH1A1 1871/4885 |
| US-20150191483-A1 | PYRROLIDINYL SULFONE RORGAMMA MODULATORS | RORC, RORB, RORA | FDPS 747/4885L3MBTL1 4665/4885ALDH1A1 1269/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.